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ABSTRACT Pneumocystis jirovecii is a fungus that causes severe pneumonia in immunocompromised patients. However, its study
is hindered by the lack of an in vitro culture method. We report here the genome of P. jirovecii that was obtained from a single
bronchoalveolar lavage fluid specimen from a patient. The major challenge was the in silico sorting of the reads from amixture
representing the different organisms of the lung microbiome. This genome lacks virulence factors andmost amino acid biosyn-
thesis enzymes and presents reduced GC content and size. Together with epidemiological observations, these features suggest
that P. jirovecii is an obligate parasite specialized in the colonization of human lungs, which causes disease only in immune-
deficient individuals. This genome sequence will boost research on this deadly pathogen.
IMPORTANCE Pneumocystis pneumonia is a major cause of mortality in patients with impaired immune systems. The availability
of the P. jirovecii genome sequence allows new analyses to be performed which open avenues to solve critical issues for this
deadly human disease. The most important ones are (i) identification of nutritional supplements for development of culture in
vitro, which is still lacking 100 years after discovery of the pathogen; (ii) identification of new targets for development of new
drugs, given the paucity of present treatments and emerging resistance; and (iii) identification of targets for development of vac-
cines.
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Pneumonia caused by Pneumocystis jirovecii (PCP) marked theonset of the AIDS epidemic and remains today the most fre-
quent AIDS-defining infection as well as a major cause of mortal-
ity in immunocompromised patients (1). The poor knowledge of
P. jirovecii biology and the absence of genome sequence are due
first of all to the fact that no in vitro culture method is presently
available. P. jirovecii microorganisms can be obtained only from
clinical specimens of patients, thus in very limited amounts and
heavily contaminated by human cells and lung flora. Here we
report the assembly of the P. jirovecii genome sequence from a
single clinical specimen of a single patient. To our knowledge, this
is the first eukaryotic genome de novo assembled out of a metag-
enome.
Whole-genome sequencing requires usually between 2 to 5 g
of pure genomicDNA, which is usually not recoverable from clin-
ical specimens without in vitro culture. To compensate, we used
cell immunoprecipitation followed by random DNA amplifica-
tion. Four bronchoalveolar lavage fluid samples (BALFs) from
patients with PCP, whowere all fortuitouslyHIVuninfected, were
retained to estimate their percentages of Pneumocystis DNA con-
tent, two of them after enrichment in P. jirovecii cells using immu-
noprecipitation (see Text S1, sections A1 and A4, in the supple-
mental material). Genomic DNA was extracted, amplified, and
sequenced by low-level Roche 454 pyrosequencing. The reads
from each BALF were assigned in silico to an organism or to a
group of organisms (Homo sapiens, P. jirovecii, fungi, bacteria, or
viruses), using a simplified classification pipeline (see Text S1,
section A5, in the supplemental material). This rough classifica-
tion established that the enrichment was effective: the proportion
of Pneumocystis DNA in the two enriched specimens was 23%
(BALF E6) and 15% (BALF E8), whereas it was only 6% (BALF
N1) and 0.7% (BALF N8) in the two nonenriched samples (see
Table S1 in the supplemental material).
P. jirovecii has been repetitively reported to be the only Pneu-
mocystis species infecting humans. However, one contribution re-
ported the presence in a single patient of P. jirovecii as well as
Pneumocystis carinii (2), the species considered to infect specifi-
cally rats. To prevent any coinfections for genome sequencing, we
applied an extensive verification to exclude the presence of an-
other Pneumocystis species or fungus than P. jirovecii in the BALFs
(see Text S1, sections A6 and A7, in the supplemental material).
We found that BALF E6 contained for undetermined reasons
multiple Pneumocystis species, whereas all three other BALFs con-
tained exclusively P. jirovecii (see Table S2 in the supplemental
material). The rest of this study was conducted on BALF E8 with
the highest load of P. jirovecii.
The selected BALF, E8, was from a patient with chronic lym-
phocytic leukemia. It was enriched in P. jirovecii cells, and the
genomicDNAextracted from itwas amplified andused forwhole-
genome sequencing. The major challenge in this study was the in
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silico sorting and assembly of P. jirovecii reads out of a mixture
representing many organisms. We iteratively built stringent as-
sembly of the reads to detect homology with the available genome
of P. carinii, as well as with other fungal genomic data. Ideally,
reads should be attributed to a single organism before an assembly
of its genome is attempted. However, this simple strategy could
not be applied here, as most raw reads were too short to be attrib-
uted to a taxonomic group through sequence comparison. More-
over, some Pneumocystis-specific reads would certainly be lost or
misidentified, as P. carinii assembly is known to be incomplete.
Hence, we have established an overall strategy for read filtration
and de novo assembly that allowed us to progressively refine and
complete the P. jirovecii genome (see Text S1, section A9, and
Fig. S1 in the supplemental material). The rRNA unit and the
mitochondrial genomewere recovered, assembled, and annotated
separately. The 18S nuclear rRNA subunit displayed 99% nucleo-
tide identity with the P. jirovecii public sequence, providing a solid
assessment of the organism identity. The repeated telomere re-
gions that contain the major surface glycoproteins were also kept
apart. The repeated regions kept apart included probably the cen-
tromeres, which were not investigated further in the absence of a
genetic or physical map. A posteriori, 25% of the reads could be
attributed to P. jirovecii (see Table S3 in the supplemental mate-
rial). In addition, we deep sequenced total RNA isolated from a
nonenriched BALF of a patient with B-cell lymphoma, which pro-
vided 2.7% of reads attributable to the fungus. The de novo assem-
bly of RNAseq data yielded 2,667 transcripts, which were used for
genome annotation and provided a glimpse into the fulminate
infection process in the human host. As previously observed for
P. carinii (3), the most abundant category of the transcripts was
annotated as major surface glycoproteins (7.2%).
The 8.1-Mb genome assembly ismade of 356 contigs (Table 1).
A total of 3,878 coding sequences were identified and annotated,
with a gene density of 481 genes per Mbp. Seventy-seven percent
of them were supported by the transcriptome data. We identified
458 single-copy orthologs that were shared by P. jirovecii and sev-
eral other fungal species, including distantly related ascomycetes
and basidiomycetes. A phylogenetic tree was computed from an
alignment of these orthologous proteins (Fig. 1). It further docu-
ments the taxonomic position of P. jirovecii close to P. carinii and
Taphrina deformans.
The most striking feature of P. jirovecii was the lack of certain
metabolic capabilities. As we previously found in P. carinii (4), the
category of amino acid metabolism pathways was underrepre-
sented in P. jirovecii (see Table S4 in the supplemental material),
and a manual analysis revealed that most enzymes specifically
dedicated to the synthesis of amino acidswere absent (see Table S5
in the supplemental material). The loss of these pathways is a
hallmark of obligate parasites (5). This strongly suggests that P. ji-
rovecii scavenges these compounds from human lungs. Accord-
ingly, an important proportion of its genes (22%) corresponded
to transporters (e.g., amino acid permeases). Such transporters
are believed to be necessary in P. carinii for scavenging amino
acids as well as other compounds, such as host cholesterol and
S-adenosylmethionine (reviewed in reference 6). The P. jirovecii
genome presents a low GC content (29%) and a smaller size than
its free-living relatives T. deformans and Schizosaccharomyces
pombe (42% and 36%, 13Mb and 14Mb, respectively). In obligate
bacterial parasites, the reduction of GC content is associated with
the reduction of genome, which in turn is generally due to a loss of
the genes responsible for the synthesis of compounds that can be
scavenged from the host (7). P. jirovecii also lacks the hallmark
enzymes of the glyoxylate cycle, a significant virulence factor of
fungal pathogens (8), as well as polyketide synthase clusters, re-
sponsible for production of secondarymetabolites, such as toxins.
Together, these features are compatible with the view that P. ji-
rovecii is an obligate parasite specialized in colonization of human
lungs, which causes deadly disease only in immunocompromised
individuals. This conclusion is further supported by the mecha-
nism of surface antigen variation (6), the coevolution with hosts
(9), and the strict host specificity of Pneumocystis spp. (10). Obli-
gate parasitism also fits epidemiological studies, which failed to
identify free-living forms as a source of infection. The host and
reservoir of P. jirovecii is likely to be only humans, including im-
munologically impaired individuals, but also infants experiencing
primo-infection (11), elderly people (12), pregnant women (13),
and healthy transitory carriers (14). Consequently, the entire life
cycle of P. jirovecii most probably takes place only within human
lungs.
For an organismof clinical importance that cannot be grown in
the laboratory as P. jirovecii, the genome sequence represents a




P. jirovecii P. cariniia
Assembly
Assembly size (Mb) 8.1 6.3
Mean 454 read depth 36 NAb
Mean Illumina read depth 1,315 NA
No. of contigs 358 4,278
N50 (kb) 41.6 2.2
Mean GC content (%) 28.4 32.5
Annotation
No. of CDSs 3,898 4,591c
Coding regions (%) 68.9 50.0
No. of KEGG orthologsd 269 252
No. of tRNA genes 77e 36f
Mean gene length (bp) 1,472 891
Mean exon length (nt) 211 223
Mean no. of introns per gene 4.5 2.3
Mean intron length (nt) 61 54
Repeat density (%) 9.86 5.71
Mitochondrial genome
Assembly size (kb) 27 23g
No. of contigs 3 1
GC content in whole genome (%) 29.5 31.1
GC content in coding genes (%) 32.5 30.9
No. of protein coding genes (CDSs) 17 17
No. of rRNA genes 2 2
No. of tRNA genes 12 20
a The P. carinii assembly was downloaded from the Pneumocystis genome project
website (http://pgp.cchmc.org/) and corresponds to the sequences published by Slaven
et al. (15). This assembly is known to be incomplete.
b Not applicable.
c Some of these peptides were derived from incomplete CDSs located at the extremity
of a contig. Hence, the numbers of predicted peptides provide only a rough estimation
of the proteome size.
d The number of KEGG orthologs was computed as described previously (4).
e Not including pseudo tRNAs.
f Only complete copies are shown; the total number of tRNAs in the genome may be
more important.
g P. cariniimitochondrion data were computed from the published genome (16).
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wealth of new information for future research. It allows new anal-
yses to be performed, such as RNA sequencing and comparative
genomics, which open avenues to solve critical issues such as (i)
the identification of nutritional supplements for culture in vitro
development; (ii) the identification of new targets for develop-
ment of newdrugs, an important issue because only antifolates are
presently efficient and development of drug resistance has been
documented; and (iii) the identification of targets for the devel-
opment of vaccines. The relevantP. jirovecii genes cannowbeused
in these studies rather than those of P. carinii as models, which is
particularly crucial for development of new drugs.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00428-12/-/DCSupplemental.
Text S1, DOCX file, 0.1 MB.
Figure S1, TIF file, 0.5 MB.
Table S1, DOCX file, 0.1 MB.
Table S2, DOCX file, 0.1 MB.
Table S3, DOCX file, 0.1 MB.
Table S4, DOCX file, 0.1 MB.
Table S5, DOCX file, 0.1 MB.
Table S6, DOCX file, 0.1 MB.
ACKNOWLEDGMENTS
This workwas supported by the Swiss National Science Foundation, grant
310030-124998. Computations were performed at the Vital-IT Center for
High-Performance Computing of the Swiss Institute of Bioinformatics
(http://www.vital-it.ch).
We are indebted to Melanie Cushion, Georges Smulian, and Alexey
Porollo for providing helpful information on P. carinii genomic data-
FIG1 Maximum likelihood phylogeny of P. jirovecii and other fungi from alignment of 458 concatenated orthologs.Rhizopus delemarwas used as the outgroup.
The same tree topology was obtained using the maximum parsimony method.
P. jirovecii Genome Assembly from a BAL Specimen
January/February 2013 Volume 4 Issue 1 e00428-12 ® mbio.asm.org 3
bases. We thank Cécile-Marie Aliouat-Denis and Chabe Magali for pro-
viding P. carinii ESTs. We thank Laurent Keller, Michel Monod, Jacques
Rougemont, Ioannis Xenarios, and Dominique Sanglard for critical read-
ing. We thank Ioannis Xenarios, Thomas Bernard, Laurent Falquet, San-
dra Calderon-Copete, Oksana Riba-Grognuz, Lorenzo Cerutti, Sébastien
Moretti, Emmanuel Beaudoing, Sylvain Pradervand, and Thomas Junier
for support and helpful discussions.
REFERENCES
1. Thomas CF, Jr, limper AH. 2007. Current insights into the biology and
pathogenesis of Pneumocystis pneumonia. Nat. Rev. Microbiol.
5:298–308.
2. Lu JJ, et al. 1994. Typing of Pneumocystis carinii strains that infect hu-
mans based on nucleotide sequence variations of internal transcribed
spacers of rRNA genes. J. Clin. Microbiol. 32:2904–2912.
3. Cushion MT, et al. 2007. Transcriptome of Pneumocystis carinii during
fulminate infection: carbohydrate metabolism and the concept of a com-
patible parasite. PLoS One 2:e423. http://dx.doi.org/10.1371/journal
.pone.0000423.
4. Hauser PM, et al. 2010. Comparative genomics suggests that the fungal
pathogen pneumocystis is an obligate parasite scavenging amino acids
from its host’s lungs. PLoS One 5:e15152. http://dx.doi.org/10.1371
/journal.pone.0015152.
5. Payne SH, Loomis WF. 2006. Retention and loss of amino acid biosyn-
thetic pathways based on analysis of whole-genome sequences. Eukaryot.
Cell 5:272–276.
6. Cushion MT, Stringer JR. 2010. Stealth and opportunism: alternative
lifestyles of species in the fungal genus Pneumocystis. Annu. Rev. Micro-
biol. 64:431–452.
7. Merhej V, Royer-Carenzi M, Pontarotti P, Raoult D. 2009. Massive
comparative genomic analysis reveals convergent evolution of specialized
bacteria. Biol. Direct 4:13.
8. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal
virulence. Nature 412:83–86.
9. Demanche C, et al. 2001. Phylogeny of Pneumocystis carinii from 18
primate species confirms host specificity and suggests coevolution. J. Clin.
Microbiol. 39:2126–2133.
10. Wakefield AE, Stringer JR, Tamburrini E, Dei-Cas E. 1998. Genetics,
metabolism and host specificity of Pneumocystis carinii. Med. Mycol.
36(Suppl 1):183–193.
11. Vargas SL, et al. 2001. Search for primary infection by Pneumocystis
carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:
855–861.
12. Vargas SL, et al. 2010. Pneumocystis colonization in older adults and
diagnostic yield of single versus paired noninvasive respiratory sampling.
Clin. Infect. Dis. 50:e19–e21.
13. Vargas SL, et al. 2003. Pregnancy and asymptomatic carriage of Pneumo-
cystis jiroveci. Emerg. Infect. Dis. 9:605–606.
14. Miller RF, Ambrose HE, Wakefield AE. 2001. Pneumocystis carinii f. sp.
hominis DNA in immunocompetent health care workers in contact with
patients with P. carinii pneumonia. J. Clin. Microbiol. 39:S89–S91.
15. Slaven BE, et al. 2006. Draft assembly and annotation of the Pneumocystis
carinii genome. J. Eukaryot. Microbiol. 53(Suppl 1):S89–S91.
16. Sesterhenn TM, et al. 2010. Sequence and structure of the linear mito-
chondrial genome of Pneumocystis carinii. Mol. Genet. Genomics 283:
63–72.
Cissé et al.
4 ® mbio.asm.org January/February 2013 Volume 4 Issue 1 e00428-12
